Episode
Diabetes and driving, GLP-1 medicines for type 2 diabetes and obesity, and more!
- Podcast
- Diabetes Care "On Air"
- Published
- Nov 1, 2024
- Duration seconds
- 2682
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/diabetes-care-on-air-5983699/episodes/diabetes-and-driving-glp-1-medicines-for-type-2-diabetes-and-obesity-and-more/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/diabetes-care-on-air-5983699/diabetes-and-driving-glp-1-medicines-for-type-2-diabetes-and-obesity-and-more.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Welcome to episode no. 26 (November 2024) of Diabetes Care "On Air"—a new and different way to bring the research published in Diabetes Care to life. Join co-hosts Alice Cheng, MD, FRCPC, and Michael Rickels, MD, MS, as they discuss the latest and greatest content in the November 2024 issue of Diabetes Care and beyond. 0:40 In the spirit of Thanksgiving, Alice and Mike begin with a special offer from the ADA for new and renewing members: a 15% discount on a 1- or 2-year membership. Go to professional.diabetes.org/membership , create your account, fill out the application, and use the discount code 'FALL24' at checkout. Act fast because this offer expires November 30, 2024! 3:00 In a Diabetes Care "On Air" first, Michael interviews not a clinician, but a lawyer. Anthony May , a law partner at Brown, Goldstein, and Levy, LLP in Baltimore, MD, is the senior author of "Diabetes and Driving: A Statement of the American Diabetes Association." This statement provides an overview of existing licensing rules for people with diabetes in the U.S., addresses the factors that affect driving ability, identifies general guidelines for assessing driver fitness and determining appropriately tailored licensing restrictions, and provides practical guidance for health care professionals regarding clinical interventions and education for people with diabetes. This review is available for free at doi.org/10.2337/dci24-0068 . 16:15 Amy is joined by Dr. Daniel J. Drucker , endocrinologist and professor of medicine at the Lunenfeld-Tanenbaum Research Institute, Mt. Sinai Hospital, University of Toronto, and one of Time Magazine's 100 most influential people of 2024. They discuss his review, "Efficacy and Safety of GLP-1 Medicines for Type 2 Diabetes and Obesity." This article is available for…